AbbVie Inc. (FRA:4AB)
Germany
· Delayed Price · Currency is EUR 155.80
+1.00 (0.65%)
At close: Apr 24, 2025, 10:00 PM CET
AbbVie Employees
AbbVie had 55,000 employees as of December 31, 2024. The number of employees increased by 5,000 or 10.00% compared to the previous year.
Employees
55,000
Change (1Y)
5,000
Growth (1Y)
10.00%
Revenue / Employee
€965,017
Profits / Employee
€69,895
Market Cap
289.64B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| SAP SE | 109,121 |
| Siemens Aktiengesellschaft | 327,000 |
| Deutsche Telekom AG | 198,194 |
| Allianz SE | 156,626 |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
| Rheinmetall AG | 28,539 |
| Siemens Energy AG | 98,000 |
| Merck KGaA | 59,020 |
AbbVie News
- 3 days ago - Cerevel Therapeutics Holdings, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights - ABBV - Accesswire
- 3 days ago - AbbVie Submits Biologics License Application to U.S. FDA for TrenibotulinumtoxinE (TrenibotE) for the Treatment of Glabellar Lines - PRNewsWire
- 3 days ago - The Gross Law Firm Reminds Cerevel Therapeutics Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025 - ABBV - PRNewsWire
- 4 days ago - Cerevel Therapeutics Holdings, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before June 3, 2025 to Discuss Your Rights – ABBV - GlobeNewsWire
- 4 days ago - Shareholders that lost money on Cerevel Therapeutics Holdings, Inc. (ABBV) should contact Levi & Korsinsky about pending Class Action - ABBV - Accesswire
- 5 days ago - Eli Lilly, Vertex, AbbVie and More Pharma Stocks to Own as Tariffs Loom - Barrons
- 5 days ago - Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Cerevel Therapeutics Holdings, Inc.(ABBV) Shareholders - PRNewsWire
- 6 days ago - Class Action Filed Against Cerevel Therapeutics Holdings, Inc. (ABBV) Seeking Recovery for Investors – Contact Levi & Korsinsky - GlobeNewsWire